CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
ASSETS
Cash and cash equivalents	$ 11,713	$ 6,174
Restricted cash and equivalents	125,684	119,257
Finance receivables measured at fair value	3,313,767	2,722,662
Finance receivables	5,420	27,553
Less: Allowance for finance credit losses	(433)	(2,869)
Finance receivables, net	4,987	24,684
Furniture and equipment, net	943	1,372
Deferred tax assets, net	1,010	3,736
Other assets	35,764	25,861
Total assets	3,493,868	2,903,746
Liabilities
Accounts payable and accrued expenses	70,151	62,544
Warehouse lines of credit	410,898	234,025
Residual interest financing	99,176	49,875
Securitization trust debt	2,594,384	2,265,446
Subordinated renewable notes	26,489	17,188
Total liabilities	3,201,098	2,629,078
COMMITMENTS AND CONTINGENCIES
Shareholders’ Equity
Common stock, no par value; authorized 75,000,000 shares; 21,432,698 and 21,174,856 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively	25,720	28,678
Retained earnings	267,060	247,857
Accumulated other comprehensive loss	(10)	(1,867)
Total shareholders’ equity	292,770	274,668
Total liabilities and shareholders’ equity	3,493,868	2,903,746
Preferred Stock [Member]
Shareholders’ Equity
Preferred stock, value	0	0
Series A Preferred Stock [Member]
Shareholders’ Equity
Preferred stock, value	0	0
Series B Preferred Stock [Member]
Shareholders’ Equity
Preferred stock, value	$ 0	$ 0

No definition available.

Name:	cpss_ResidualInterestFinancing
Namespace Prefix:	cpss_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.